S-[1-(2,3-DIAMINOPHENOXY)]-3'-(N-TERT-BUTYLAMINO)PROPAN-2'-OL - SIMPLIFIED ASYMMETRIC-SYNTHESIS WITH CD AND CHIRAL HPLC ANALYSIS

被引:18
作者
AIGBIRHIO, F
PIKE, VW
FRANCOTTE, E
WATERS, SL
BANFIELD, B
JAEGGI, KA
DRAKE, A
机构
[1] HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,DUCANE RD,LONDON W12 0HS,ENGLAND
[2] CIBA GEIGY AG,PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[3] UNIV LONDON BIRKBECK COLL,DEPT CHEM,LONDON WC1H 0AJ,ENGLAND
关键词
S-[1-(2,3-DIAMINOPHENOXY)]-3'-(N-T-BUTYLAMINO)PROPAN-2'-OL; ASYMMETRIC SYNTHESIS; CHIRAL HPLC; CD; S-[CARBONYL-C(11)]CGP-12177;
D O I
10.1016/S0957-4166(00)80261-X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
S-[1-(2,3-Diaminophenoxy)]-3'-(N-t-butylamino)propan-2'-ol is important as a precursor in the radiosynthesis of a C-11-labelled radioligand (S-[carbonyl-C-11]CGP 12177) for the study of beta-receptors in living man. The asymmetric synthesis of this precursor has been simplified based on the reaction of readily available 2-amino-3-nitrophenol and the chiral auxiliary, S-glycidyl-3-nitrobenzenesulphonate, followed by treatment of the resultant S-epoxide with t-butylamine and reduction with hydrogen in the presence of palladium on carbon. Chiral HPLC methods have been successfully developed to monitor the enantiomeric purity of the chiral auxiliary and of all intermediates in the asymmetric synthesis. All intermediates and products have been studied by CD. It has been demonstrated by chiral HPLC that S-CGP 12177 can be prepared in > 98.4% e.e. from the synthesised S-precursor. R-CGP 12177 (e.e. > 96.2%) was prepared analogously.
引用
收藏
页码:539 / 554
页数:16
相关论文
共 35 条
[1]   (-)-S-[H-3]CGP-12177 AND ITS USE TO DETERMINE THE RATE CONSTANTS OF UNLABELED BETA-ADRENERGIC ANTAGONISTS [J].
AFFOLTER, H ;
HERTEL, C ;
JAEGGI, K ;
PORTENIER, M ;
STAEHELIN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) :925-929
[2]   DITHIOLS .23. OPTICALLY ACTIVE FORMS OF 2,3-DIMERCAPTOPROPANOL AND RELATED THIOLS [J].
ANISUZZAMAN, AK ;
OWEN, LN .
JOURNAL OF THE CHEMICAL SOCIETY C-ORGANIC, 1967, (11) :1021-+
[3]   CHIRALITY IN BIOACTIVE AGENTS AND ITS PITFALLS [J].
ARIENS, EJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (05) :200-205
[4]   APPROACH TO PERIPHERAL VASODILATOR BETA-ADRENERGIC BLOCKING-AGENTS [J].
BALDWIN, JJ ;
HIRSCHMANN, R ;
LUMMA, PK ;
LUMMA, WC ;
PONTICELLO, GS ;
SWEET, CS ;
SCRIABINE, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (08) :1024-1029
[5]  
BOULLAIS C, 1985, J LABELLED COMPD RAD, V23, P565
[6]  
BRADY F, 1991, APPL RADIAT ISOTOPES, V42, P621
[7]  
BRADY F, 1990, J LABELLED COMPD RAD, V30, P251
[8]   DEBRISOQUINE-TYPE POLYMORPHISM OF DRUG OXIDATION - PURIFICATION FROM HUMAN-LIVER OF A CYTOCHROME-P450 ISOZYME WITH HIGH-ACTIVITY FOR BUFURALOL HYDROXYLATION [J].
GUT, J ;
GASSER, R ;
DAYER, P ;
KRONBACH, T ;
CATIN, T ;
MEYER, UA .
FEBS LETTERS, 1984, 173 (02) :287-290
[9]   ASYMMETRIC-SYNTHESIS OF (2S) AND (2R)-4-(3-T-BUTYLAMINO-2-HYDROXYPROPOXY)-BENZIMIDAZOL-2-[C-11]-ONE ((S) AND (R)-[C-11]-CGP-12177) FROM OPTICALLY-ACTIVE PRECURSORS [J].
HAMMADI, A ;
CROUZEL, C .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1991, 29 (06) :681-690